The Global Genotyping Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 14.59% over the forecast period 2024-2032. Request To ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most undervalued large cap stocks to buy according to analysts. On ...

The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

The FDA approves a rapid test for identifying patients with NSCLC eligible for sunvozertinib, enhancing timely, precision ...

Recent advancements in electrochemical detection have created significant opportunities in biosensing, particularly in medical diagnostics and health monitoring, where real-time response, high ...

The global Molecular Biology Enzymes, Kits & Reagents Market is estimated to be valued at USD 25,900.5 million in 2025 and is projected to reach USD 64,187.5 million by 2035, registering a CAGR of 9.5 ...

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

According to a comprehensive market research report titled "Protein Expression Market by System (Mammalian [CHO, HEK 293], ...

According to a comprehensive market research report titled "Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...